Altered fibrin clot structure in the healthy relatives of patients with premature coronary artery disease.
about
Spatiotemporal characterization of a fibrin clot using quantitative phase imagingStatins, fenofibrate, and quinapril increase clot permeability and enhance fibrinolysis in patients with coronary artery diseaseFibrin clot structure and platelet aggregation in patients with aspirin treatment failure.Natural selection and the molecular basis of electrophoretic variation at the coagulation F13B locus.S-nitrosoglutathione acts as a small molecule modulator of human fibrin clot architectureMolecular mechanisms affecting fibrin structure and stability.Causal relationship between hyperfibrinogenemia, thrombosis, and resistance to thrombolysis in mice.Low fasting glucose is associated with enhanced thrombin generation and unfavorable fibrin clot properties in type 2 diabetic patients with high cardiovascular risk.The pathophysiology, diagnosis and treatment of the acute coagulopathy of trauma and shock: a literature review.Unfavorably Altered Fibrin Clot Properties in Patients with Eosinophilic Granulomatosis with Polyangiitis (Churg-Strauss Syndrome): Association with Thrombin Generation and Eosinophilia.Procoagulant changes in fibrin clot structure in patients with cirrhosis are associated with oxidative modifications of fibrinogen.Endothelial fibrinolytic response onto an evolving matrix of fibrin.Role of clotting factors and fibrin structure in predisposition to atherothrombotic disease.Roles of transglutaminases in cardiac and vascular diseases.Hyperglycemia is associated with enhanced thrombin formation, platelet activation, and fibrin clot resistance to lysis in patients with acute coronary syndrome.Altered clot microstructure detected in obstructive sleep apnoea hypopnoea syndrome.Fibrinogen beta-chain tyrosine nitration is a prothrombotic risk factorEffects of unidirectional flow shear stresses on the formation, fractal microstructure and rigidity of incipient whole blood clots and fibrin gels.Characteristics of fibrin formation and clot stability in individuals with congenital type IIb protein C deficiencyComplement activation: an emerging player in the pathogenesis of cardiovascular diseaseHypofibrinolysis in diabetes: a therapeutic target for the reduction of cardiovascular risk.Fibrin(ogen) and thrombotic disease.Importance of Endogenous Fibrinolysis in Platelet Thrombus Formation.What Is the Biological and Clinical Relevance of Fibrin?Reduced plasma fibrin clot permeability and susceptibility to lysis are associated with increased risk of postthrombotic syndrome.Characterisation of clot microstructure properties in stable coronary artery disease.Fibrin architecture in clots: a quantitative polarized light microscopy analysisConformational quiescence of ADAMTS-13 prevents proteolytic promiscuity.A comparison of cardiovascular risk indices in patients with polycystic ovary syndrome with and without coexisting nonalcoholic fatty liver disease.Fibrinogen and clot-related phenotypes determined by fibrinogen polymorphisms: Independent and IL-6-interactive associations.Insulin resistance and cardiovascular risk marker evaluation in morbid obesity 12 months after bariatric surgery compared to weight-matched controls.Adopting automated image analysis tool for fibrin network: Can we obtain clot properties for practical application?Increased risk of coronary heart disease in male patients with central serous chorioretinopathy: results of a population-based cohort study.Aspirin therapy is associated with less compact fibrin networks and enhanced fibrinolysis in patients with abdominal aortic aneurysm.Raised plasma fibrinogen concentration in patients with abdominal aortic aneurysm.A new biomarker quantifies differences in clot microstructure in patients with venous thromboembolism.Fibrinogen and Fibrin in Hemostasis and Thrombosis.
P2860
Q27333692-518E44B7-361F-4B22-9D80-D3E5E2D13DF0Q28217889-123E782C-E3A4-475D-A738-5F9718F80BB3Q31126985-911C676B-EFEF-4D43-BD49-3D8E866842BDQ34325637-8B14EE3D-AC4A-4044-89AB-B5B37C1B99FFQ34391779-45F5CB30-D876-4C46-927B-43E23C8BC9E2Q34759786-7BB98B43-DD58-4F06-AB5A-EF4B15F246ACQ35001664-5B5EC03E-BE2B-4A44-B80E-07A43ED035A8Q35609789-1CC4F60E-FCA7-41AA-A2B9-6DA3517027BDQ35650554-47FEB516-71A6-4162-B91C-67C45524E085Q35833396-98C12C79-97EB-42F3-B515-A0C3271993F4Q35911484-D50EE719-F7AC-4590-AB6C-7DD367BC6A79Q35990777-6476CB47-B2FA-42C6-BE1A-E66062734603Q36314852-FDAEEF5D-3AD0-4817-B903-861A5BCEC0EBQ36664166-1532212C-4654-4BFC-B98A-2FB399A4C546Q36807512-04503454-0B94-4C33-B0C9-4EEC8B86E2A2Q36903788-7D67DE28-5537-4DD7-BF30-EBF351C575E4Q36990172-F356BA6C-03A6-466F-8583-10CEC3D997B2Q37044188-049D379D-9AF3-46F0-AE6F-50C5D33712B1Q37059445-569AB7E2-2523-4E71-A27E-E874BFAD8934Q37288362-FAF4C3D8-B27C-4103-9258-373A48DA969FQ37692590-A18ACB75-C23B-4F3B-9D0B-16D1640B53C2Q38117741-32FF653A-5A68-4730-925C-878E88D8D91EQ38637328-B946D1A6-3D4E-4D63-8C63-EDC7336EE063Q38801282-1F4CFF08-165D-451F-98C9-E4D7360A13DDQ40087127-746C1EEE-E85E-4B86-BEAA-27F3E8BB97F4Q41045595-F69246A5-09A4-425B-8480-492173FD37A2Q41807904-8D2814FA-B6BD-4ABF-967C-B283955C2081Q41946735-A3C370A8-9703-4F8B-9EDA-24B6CBE24829Q45796522-B3651298-20E5-41E1-BF70-06A9BB001A06Q46787524-C2F2EDEA-A93A-4CE6-96CE-295BA722A6B3Q47201378-80B050A4-4C6F-46F8-AAE3-2A4AD6571CA1Q48149253-FD8C2418-1745-4256-9AFE-8241268DCCB5Q51189472-53225644-55D1-4908-BC20-FD6A8F1748B7Q52837825-6448D627-7B5E-4460-A71F-AEFE414C2FE8Q52854977-C7E15C72-825F-447D-84BA-88609B47724DQ53083051-999EB7F2-112E-4FD6-AC8D-45773A2299A1Q54842287-A846AFE4-BDCD-47ED-91B6-1FC601A53E54
P2860
Altered fibrin clot structure in the healthy relatives of patients with premature coronary artery disease.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Altered fibrin clot structure ...... ature coronary artery disease.
@en
Altered fibrin clot structure ...... ature coronary artery disease.
@en-gb
Altered fibrin clot structure ...... ature coronary artery disease.
@nl
type
label
Altered fibrin clot structure ...... ature coronary artery disease.
@en
Altered fibrin clot structure ...... ature coronary artery disease.
@en-gb
Altered fibrin clot structure ...... ature coronary artery disease.
@nl
prefLabel
Altered fibrin clot structure ...... ature coronary artery disease.
@en
Altered fibrin clot structure ...... ature coronary artery disease.
@en-gb
Altered fibrin clot structure ...... ature coronary artery disease.
@nl
P1433
P1476
Altered fibrin clot structure ...... ature coronary artery disease.
@en
P2093
Joseph D Mills
Peter J Grant
P304
P356
10.1161/01.CIR.0000033221.73082.06
P407
P577
2002-10-01T00:00:00Z